MannKind (MNKD)
(Delayed Data from NSDQ)
$4.86 USD
+0.08 (1.67%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $4.84 -0.02 (-0.41%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Brokerage Reports
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 61 - 80 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Dec 4
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Oct 30
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended September 4th
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 28
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D